Conclusions
Significant expression of insulin-sensitive cells and the IGF-I-binding protein CTGF was observed in the cellular hyperplasia areas of the spinal ligament sites and Achilles tendon ectopic ossifi cation sites of Zucker fatty rats. We prepared MSG-treated rats, which exhibit hyperleptinemia and hyperinsulinemia from 6 months of age onward, as in ZFRs; however, as in other rats with dietary obesity, no ligament ossifi cation changes were seen at the spinal ligament sites.
Moreover, significantly more expression of IRS-1 was observed in the hypertrophic chondrocytes and juvenile osteoblasts in the cell hyperplasia areas of the spinal ligaments of the ZFRs, and there was little expression of IRS-2 in the ZFRs compared to the other groups. Therefore, a difference in sensitivity between the insulin receptor substrates (i.e., a decrease in IRS-2 and a corresponding increase in IRS-1) due to hyperinsulinemia and hyperleptinemia is thought to be involved, suggesting that an increase in bone metabolism mediated by IRS-1 is the cause of the ossifi cation at the spinal ligament sites in ZFRs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akune T (2004) Investigation of factors associated with glucose metabolism in ossification of the posterior spinal ligament. Orthop Surg 45:19–23
Zucker LM, Antoniades HN (1972) Insulin and obesity in the Zucker genetically obese rat “fatty.” Endocrinology 90:1320–1330
Yamamoto K (2002) Spinal ligament ossification in the Zucker fatty rat. The Bone 16(3):225–233
Nishida T, Nakanishi T, Asano M, Shimo T, Takigawa M (2000) Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J Cell Physiol 184:197–206
Furukawa K (2002) Molecular mechanism of insulin resistance. Bunshi Kekkanbyo 3(2):15–21
Sugihara S (2003) Child development and leptin. Bio Clin 18(1):54–58
Takeda S, Karsenty G (2003) Central modulation of bone metabolism by leptin: mechanism mediated by the sympathetic nervous system. Mol Med 40:696–701
Olney JW (1969) Brain lesion, obesity and other disturbances in mice treated with monosodium glutamate. Science 164:719–721
Yamazaki M (2001) Analysis of bone formation (bone resorption factors) and spinal ligament tissue in obesity and NIDDM model rats (OLETF). 2000 Research reports on studies on measures to treat MHLW specially-designated diseases. Surveys and studies on spinal ligament ossification, pp 92–94
Ogata N (2000) Insulin receptor substrate-1 in osteoblasts is indispensable for maintaining bone turnover. J Clin Invest 105:935–943
Akune T, Ogata N, Hoshi K, Kubota N, Terauchi Y, Tobe K, Takagi H, Azuma Y, Kadowaki T, Nakamura K, Kawaguchi H (2002) Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J Cell Biol 159:147–156
Hoshi K (2004) Examination of the bone-forming ability of insulin-receptor-substrate-2-deficient mice. The Bone 18(2):123–126
Nakajima K (1998) Signal transmission mechanism of the leptin receptor. Bio Clin 13(2):29–34
Kawaguchi H (2002) Molecular mechanism of osteoporosis due to aging. J Jpn Soc Bone Morphometry 12:43–50
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer
About this chapter
Cite this chapter
Yamamoto, K., Kubo, K. (2006). Study of Ligament Ossification and Abnormal Glucose Tolerance in the Zucker Fatty Rat. In: Yonenobu, K., Nakamura, K., Toyama, Y. (eds) OPLL. Springer, Tokyo. https://doi.org/10.1007/978-4-431-32563-5_13
Download citation
DOI: https://doi.org/10.1007/978-4-431-32563-5_13
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-32561-1
Online ISBN: 978-4-431-32563-5
eBook Packages: MedicineMedicine (R0)